tradingkey.logo

Arcadia Biosciences Inc

RKDA
1.800USD
+0.040+2.27%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
2.46MMarktkapitalisierung
VerlustKGV TTM

Arcadia Biosciences Inc

1.800
+0.040+2.27%

mehr Informationen über Arcadia Biosciences Inc Unternehmen

Arcadia Biosciences, Inc. is a producer and marketer of plant-based health and wellness products. The Company’s product portfolio includes Zola Coconut Water (Zola) and Agronomic Wheat Traits. Zola is a natural, 100% coconut water. Zola is a non-genetically modified organisms (non-GMO) project verified and only contains 60 calories per serving. Zola flavors include original, original with pulp, espresso, lime and pineapple. The recipe with Zola includes smoothies, desserts, cocktails and mocktails, and bowls. It has developed a portfolio of non-GMO specialty wheat traits to offer healthier, nutrient-rich wheat options while providing the same baking quality, taste, and texture as traditional wheat. Its non-GMO Reduced Gluten High Fiber Wheat has fewer allergenic glutens and higher fiber than traditional wheat, while its non-GMO Extended Shelf-Life Wheat extends the shelf life of milled whole wheat flour.

Arcadia Biosciences Inc Informationen

BörsenkürzelRKDA
Name des UnternehmensArcadia Biosciences Inc
IPO-datumMay 15, 2015
CEOSchaefer (Thomas J)
Anzahl der mitarbeiter9
WertpapierartOrdinary Share
GeschäftsjahresendeMay 15
Addresse5956 Sherry Lane
StadtDALLAS
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl75225
Telefon12149748921
Websitehttps://arcadiabio.com/
BörsenkürzelRKDA
IPO-datumMay 15, 2015
CEOSchaefer (Thomas J)

Führungskräfte von Arcadia Biosciences Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Kevin J. Comcowich
Mr. Kevin J. Comcowich
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
--
--
Ms. Amy J. Yoder
Ms. Amy J. Yoder
Independent Director
Independent Director
--
--
Dr. Albert D. Bolles, Ph.D.
Dr. Albert D. Bolles, Ph.D.
Independent Director
Independent Director
--
--
Ms. Lilian Shackleford Murray
Ms. Lilian Shackleford Murray
Independent Director
Independent Director
--
--
Ms. Deborah D. (Debbie) Carosella
Ms. Deborah D. (Debbie) Carosella
Independent Director
Independent Director
--
--
Mr. Thomas J. Schaefer
Mr. Thomas J. Schaefer
President, Chief Executive Officer, Interim Chief Financial Officer
President, Chief Executive Officer, Interim Chief Financial Officer
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Kevin J. Comcowich
Mr. Kevin J. Comcowich
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
--
--
Ms. Amy J. Yoder
Ms. Amy J. Yoder
Independent Director
Independent Director
--
--
Dr. Albert D. Bolles, Ph.D.
Dr. Albert D. Bolles, Ph.D.
Independent Director
Independent Director
--
--
Ms. Lilian Shackleford Murray
Ms. Lilian Shackleford Murray
Independent Director
Independent Director
--
--
Ms. Deborah D. (Debbie) Carosella
Ms. Deborah D. (Debbie) Carosella
Independent Director
Independent Director
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
United States
4.90M
97.19%
Canada
109.00K
2.16%
Argentina
26.00K
0.52%
India
7.00K
0.14%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Mon, Nov 17
Aktualisiert: Mon, Nov 17
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
0.64%
Geode Capital Management, L.L.C.
0.60%
Mariner Wealth Advisors
0.56%
State Street Investment Management (US)
0.56%
DRW Securities, LLC
0.46%
Andere
97.18%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
0.64%
Geode Capital Management, L.L.C.
0.60%
Mariner Wealth Advisors
0.56%
State Street Investment Management (US)
0.56%
DRW Securities, LLC
0.46%
Andere
97.18%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
1.69%
Investment Advisor/Hedge Fund
1.15%
Individual Investor
0.51%
Hedge Fund
0.08%
Research Firm
0.05%
Andere
96.51%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
32
64.93K
2.98%
-224.68K
2025Q3
30
58.96K
4.31%
-249.34K
2025Q2
35
87.93K
6.43%
-234.13K
2025Q1
38
87.93K
6.43%
-244.41K
2024Q4
49
156.69K
11.48%
-110.76K
2024Q3
49
100.21K
9.85%
-202.17K
2024Q2
47
71.82K
7.77%
-229.97K
2024Q1
51
258.53K
25.32%
-38.12K
2023Q4
56
321.69K
30.80%
+98.94K
2023Q3
62
165.26K
19.23%
-273.71K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
14.04K
1.02%
--
--
Sep 30, 2025
Geode Capital Management, L.L.C.
13.00K
0.95%
+206.00
+1.61%
Sep 30, 2025
Mariner Wealth Advisors
12.26K
0.89%
-2.24K
-15.42%
Sep 30, 2025
State Street Investment Management (US)
12.15K
0.88%
--
--
Sep 30, 2025
DRW Securities, LLC
10.03K
0.73%
+10.03K
--
Sep 30, 2025
Jacot (Stanley Jr)
5.00K
0.36%
--
--
Oct 31, 2025
Schaefer (Thomas J.)
2.82K
0.21%
--
--
Oct 31, 2025
Kawakami (Mark)
2.68K
0.2%
--
--
Oct 31, 2025
Tower Research Capital LLC
1.69K
0.12%
-228.00
-11.91%
Sep 30, 2025
Morgan Stanley & Co. LLC
606.00
0.04%
-179.00
-22.80%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Name
Anteil
Keine Daten

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Feb 28, 2023
Merger
40→1
Feb 28, 2023
Merger
40→1
Feb 28, 2023
Merger
40→1
Feb 28, 2023
Merger
40→1
Datum
Ex-Dividendentag
Art
Verhältnis
Feb 28, 2023
Merger
40→1
Feb 28, 2023
Merger
40→1
Feb 28, 2023
Merger
40→1
Feb 28, 2023
Merger
40→1
KeyAI